Pan-tumor MRD Study

Summary

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Muscle Invasive Bladder Urothelial Carcinoma
• Esophageal Cancer
• Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
• Melanoma (Skin Cancer)
• NSCLC (Non-small Cell Lung Cancer)
• Pancreatic (Exocrine Only)
• Mix of Solid Tumors (MOST)

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

Paradigm Health

Last updated on ClinicalTrials.gov

September 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites